Moleculin Biotech SEC Filings
NASDAQ: MBRXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
0.442+0.018 (+4.25%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Moleculin Biotech filing overview
This page lists 1 recent SEC filings by Moleculin Biotech (MBRX), including 1 8-K. The latest current report (8-K), used to disclose material events such as earnings releases and executive changes, was filed on Oct 9, 2026. Form 10-K is the audited annual report, 10-Q the quarterly report, 8-K covers material events, and Form 4 reports insider transactions. All documents link directly to SEC EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
MBRX SEC filings
| Filed | Form | Description | Document |
|---|---|---|---|
| Oct 9, 2026 | 8-K | Departure or Appointment of Directors or Officers; Compensatory Arrangements; Submission of Matters to a Vote of Security Holders | View on EDGAR |